Caitong International Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$963 Buy
+66
New +$637 ﹤0.01% 1557
2026
Q1
Sell
-696
Closed -$8.19K 2893
2025
Q4
$8.19K Sell
696
-716
-51% -$7.72K ﹤0.01% 1172
2025
Q3
$10.9K Buy
1,412
+1,242
+731% +$8.7K 0.01% 988
2025
Q2
$1.24K Sell
170
-26
-13% -$210 ﹤0.01% 1524
2025
Q1
$1.86K Buy
+196
New +$2.45K ﹤0.01% 1375

Other funds holding NEO

Caitong International Asset Management's NEO Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in NeoGenomics (NEO) in Q2 2026: 66 shares worth $963. The stake represents ﹤0.01% of the portfolio and ranks #1557 among its holdings. This is a return to the name: Caitong International Asset Management previously reported a position in NEO as recently as Q4 2025.

Caitong International Asset Management first reported a position in NEO in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.9K in Q3 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Caitong International Asset Management held 66 shares of NeoGenomics worth $963 as of Q2 2026.
  • NeoGenomics was a new Caitong International Asset Management position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1557 holding.
  • Caitong International Asset Management first reported a position in NeoGenomics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's NeoGenomics position peaked at $10.9K in Q3 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.